SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-112395
Filing Date
2024-10-03
Accepted
2024-10-03 16:45:40
Documents
3
Period of Report
2024-10-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A apvo-2024-def14a_-_sept_.htm DEF 14A 341424
2 GRAPHIC img169411897_0.jpg GRAPHIC 945828
3 GRAPHIC img169411897_1.jpg GRAPHIC 665548
  Complete submission text file 0000950170-24-112395.txt   2561694
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37746 | Film No.: 241352120
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)